Recent research and developmental strategy of anti-asthma drugs

Pharmacology and Therapeutics

Volumn 133, Issue 1, 2012, Pages 70-78

  Nagai, Hiroichi ^a  

^a Gifu Junior College of Health Science   (Japan)

Author keywords

Allergic inflammation; Asthma; Controller; Glucocorticoid; Immunomodulator; Lipid mediator; Reliever

Indexed keywords

1 [2 HYDROXY 3 PROPYL 4 [[4 (1H TETRAZOL 5 YLMETHYL)PHENOXY]METHYL]PHENYL]ETHANONE; 15 CYCLOPENTYL 14 OXO 13 AZA 16,17,18,19,20 PENTANORPINANE THROMBOXANE A2; 4 (4 CARBOXYPHENYLTHIO) 7 [4 (4 PHENOXYBUTOXY)PHENYL] 5 HEPTENOIC ACID; 4 BROMO 5 (3 ETHOXY 4 METHOXYBENZYLAMINO) 3(2H) PYRIDAZINONE; 6 (1 PYRROLIDINYL) N (1H TETRAZOL 5 YL) 2 PYRAZINECARBOXAMIDE; 7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; ANTIASTHMATIC AGENT; AUTACOID; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DOMITROBAN; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE; IMMUNOMODULATING AGENT; IPRATROPIUM BROMIDE; KP 496; KZ 404; LEUKOTRIENE DERIVATIVE; MONTELUKAST; N [3 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY] 4 CHLORO 6 METHYLPHENYL] 1H TETRAZOLE 5 CARBOXAMIDE; ON 579; OZAGREL; PRANLUKAST; PREDNISOLONE; PROCATEROL; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN D2 RECEPTOR ANTAGONIST; PROSTAGLANDIN E2 RECEPTOR ANTAGONIST; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RAMATROBAN; RS 601; SALBUTAMOL; SERATRODAST; SUPLATAST TOSYLATE; THEOPHYLLINE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; TRANILAST; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAFIRLUKAST;

ALLERGIC ASTHMA; ARTICLE; ASTHMA; CELLULAR IMMUNITY; DRUG EFFICACY; DRUG RESEARCH; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL; THEORETICAL MODEL;

EID: 83555173638     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.09.001     Document Type: Review

References (134)

1. D.K. Agrawal, G. Cheng, M.J. Kim, and M. Kiniwa Interaction of suplatast tosilate (IPD-1151T) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects Clin Exp Allergy 38 2007 305 312
2. H. Akabane, M. Murata, M. Kubota, E. Takashima, H. Tanaka, and N. Inagaki Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells Allegol Int 55 2006 387 393
3. L. Akhabir, and A. Sandford Genetics of interleukin 1 receptor like 1 in immune and inflammatory diseases Curr Genomics 11 2011 591 606
4. M. Anselmo Pediatric asthma controller therapy Paediatr Drugs 13 2011 11 17
5. M. Arima, and T. Fukuda Prostaglandin D2 receptors DP and CRTH2 in the pathogenesis of asthma Curr Mol Med 8 2008 365 375
6. K. Asano, T. Mizutani, T. Shimane, M. Hisano, T. Hisamitsu, and H. Suzaki The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced broncho-constriction in sensitized mice Mediators Inflamm 9 2000 77 84
7. N. Barnes, J. Evans, J. Zakrzewski, P. Piper, and J. Costello Pharmacology and physiology of leukotrienes and their antagonists Ann N Y Acad Sci 524 1988 369 378
8. P.J. Barnes, R.A. Dweik, A.F. Gelb, P.G. Gibson, S.C. George, and H. Grasemann Exhaled nitric oxide in pulmonary diseases: a comprehensive review Chest 138 2010 682 692
9. W. Berger, M.T. De Chandt, and C.B. Cairns Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease Int J Clin Pract 61 2007 663 676
10. A. Bodzenta-Lukaszyk, A. Dymek, K. McAulay, and H. Mansikka Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study BMC Pulm Med 11 2011 28
11. A. Bodzenta-Lukaszyk, G. Pulka, A. Dymek, D. Bumbacea, T. McIver, and B. Schwab Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler Respir Med 105 2011 674 682
12. M.A. Bray, D. Gordon, and J. Morley Prostaglandins as regulators in cellular immunity Prostaglandins Med 1 1978 183 199
13. D.H. Broide Immunomodulation of allergic disease Annu Rev Med 60 2009 279 291
14. C. Buccellati, F. Fumagalli, S. Viappiani, and G. Folco Leukotriene modifiers: novel therapeutic opportunities in asthma Farmaco 57 2002 235 242
15. M. Capron, G. Woerly, H. Kayaba, S. Loiseau, N. Roser, and D. Dombrowicz Role of membrane receptors in the release of T helper 1 and 2 cytokines by eosinophils Int Arch Allergy Immunol 124 2001 223 226
16. A.T. Clark, I. Skypala, S.C. Leech, P.W. Ewan, P. Dugué, and N. Brathwaite British society for allergy and clinical immunology guidelines for the management of egg allergy Clin Exp Allergy 40 2010 1116 1129
17. S.E. Dahlén, B. Dahlén, and J.M. Drazen Asthma treatment guidelines meet the real world N Engl J Med 364 2011 1769 1770
18. U.N. Das Auto-immunity and prostaglandins Int J Tissue React 3 1981 89 94
19. P. Duramad, and N.T. Holland Biomarkers of immunotoxicity for environmental and public health research Int J Environ Res Public Health 8 2011 1388 1401
20. T. Eiwegger, and C.A. Akdis IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma Eur J Immunol 41 2011 1535 1538
21. P.M. Enarson, D.A. Enarson, and R. Gie Management of asthma children in low-income countries Int J Tuberc Lung Dis 9 2005 1204 1209
22. L. Fang, B. Adkins, V. Deyev, and E.R. Podack Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation J Exp Med 205 2008 1037 1048
23. D.E. Fonseca, and J.N. Kline Use of CpG oligonucleotides in treatment of asthma and allergic disease Adv Drug Deliv Rev 61 2009 256 262
24. E. Galli, S. Gianni, G. Auricchio, E. Brunetti, G. Mancino, and P. Rossi Atopic dermatitis and asthma Allergy Asthma Proc 28 2007 540
25. P.O. Girodet, A. Ozier, I. Bara, J.M. Tunon de Lara, R. Marthan, and P. Berger Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention Pharmacol Ther 130 2011 325 337
26. K. Gomi, F.G. Zhu, and J.S. Marshall Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte- macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism J Immunol 165 2000 6545 6552
27. B.R. Gordon The allergic march: can we prevent allergies and asthma? Otolaryngol Clin North Am 44 2011 765 777
28. G.K. Gupta, and D.K. Agrawal CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma BioDrugs 24 2010 225 235
29. J.Z. Haeggström, A. Rinaldo-Matthis, C.E. Wheelock, and A. Wetterholm Advance in eicosanoid research, novel therapeutic implications Biochem Biophys Res Commun 396 2010 135 139
30. C. Hahn, and K.J. Erb The preclinical strategy for the development of novel chemical entities for the treatment of asthma Curr Drug Targets 9 2008 443 451
31. A.J. Halayko, T. Tran, S.Y. Ji, A. Yamasaki, and R. Gosens Airway smooth muscle phenotype and function: interactions with current asthma therapies Curr Drug Targets 7 2006 525 540
32. R.J. Hancox, D.A. Stevens, I.M. Adcock, P.J. Barnes, and D.R. Taylor Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma Thorax 54 1999 488 492
33. A.T. Hillel, L.M. Lin, R. Samlan, H. Starmer, K. Leahy, and P.W. Flint Inhaled triamcinolone with proton pump inhibitor for treatment of vocal process granulomas: a series of 67 granulomas Ann Otol Rhinol Laryngol 119 2010 325 330
34. I. Hirose, H. Tanaka, G. Takahashi, K. Wakahara, M. Tamari, and T. Sakamoto Immunomodulatory effects of CpG oligodeoxynucleotides on house dust mite-induced airway inflammation in mice Int Arch Allergy Appl Immunol 147 2008 6 16
35. L.J. Hoeksema, A. Bazzy, E.A. Lemotan, D.E. Edmonds, G. Ramirez-Garnica, and R.N. Shiffman Accuracy of a computerized clinical decision-support system for asthma assessment and management J Am Med Inform Assoc 18 2011 243 250
36. T. Horiguchi, R. Kondo, J. Miyazaki, M. Shiga, M. Hirose, and T. Ito Usefulness of suplatast tosilate in patients with mild bronchial asthma-comparison with beclomethasone dipropionate Allergol Int 54 2005 131 135
37. T. Horiguchi, S. Tachikaewa, M. Handa, K. Hanazono, R. Kondo, and A. Ishibasi Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness J Asthma 38 2001 331 336
38. L.W. Hst, C.H. Yang, S. Goto, T. Nakano, C.Y. Lai, and Y.C. Lin The effect of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells Transpl Immunol 18 2007 108 114
39. H. Iijima, G. Tamura, T.R. Hsiue, Y. Liu, H. Taniguchi, and K. Shirato Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs Am J Respir Crit Care Med 160 1999 331 335
40. Y. Ishiura, M. Fujimura, C. Yamamori, K. Nobata, S. Myou, and K. Kurashima Thromboxane antagonism and cough in chronic bronchitis Ann Med 35 2003 135 139
41. Y. Ishiura, M. Fujumura, K. Nobata, S. Myou, Y. Oribe, and M. Abo Th2 cytokine inhibition and cough in asthmatic and bronchitic patients Ann Med 36 2004 623 629
42. M. Johnson Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease Proc Am Thorac Soc 1 2004 200 206
43. K. Kabashima, T. Murata, H. Tanaka, T. Matsuoka, D. Sakata, and N. Yoshida Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity Nat Immunol 4 2003 694 701
44. N. Kawada, T. Yamada, Y. Takahashi, S. Tokuoka, T. Masuda, and H. Tanaka The effect of leukotriene D(4) inhalation on the antigen-induced airway hyperresponsiveness and inflammation in 5-lipoxygenase gene-deficient mice Int Arch Allergy Immunol 126 2001 309 317
45. S.J. Keam, K.A. Lyseng-Williamson, and K.L. Goa Pranlukast: a review of its use in the management of asthma Drugs 63 2003 991 1019
46. Y.S. Kim, Y. Kim, H.J. Kwan, K.L. Lee, and D.S. Kim Involvement of AD in NC/Nga mice by topical application of CpG Int Arch Allergy Immunol 144 2007 315 324
47. J.N. Kline, and A.M. Krieg Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy Drug News Perspect 21 2008 434 439
48. C.A. Knosp, H.P. Carroll, J. Elliott, S.P. Saunders, H.J. Nel, and S. Amu SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses J Exp Med 2011 Jun 6. [Epub]
49. N. Kondo, E. Matsui, A. Nishimura, and H. Kaneko Pharmacogenetics of asthma in children Allergy Asthma Immunol Res 2 2010 14 19
50. H.S. Kuehn, M.Y. Jung, M.A. Beaven, D.D. Metcalfe, and A.M. Gilfillan Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release J Biol Chem 286 2011 391 402
51. T. Kunikata, H. Yamane, E. Segi, T. Matsuoka, Y. Sugimoto, and S. Tanaka Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3 Nat Immunol 6 2005 524 531
52. C. Libetta, P. Esposito, V. Sepe, C. Guastoni, M. Zucchi, and F. Meloni Effects of different peritoneal-dialysis fluids on the TH1/TH2 balance Eur Cytokine Netw 22 2011 24 31
53. J.J. Lima Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers Mol Diagn Ther 11 2007 97 104
54. A.A. Long Immunomodulators in the treatment of asthma Allergy Asthma Proc 30 2009 109 119
55. N.W. Lukacs, A.A. Berlin, K. Franz-Bacon, R. Sásik, L.J. Sprague, and T.W. Ly CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation Am J Physiol Lung Cell Mol Physiol 295 2008 L767 L779
56. A. Lundequist, S.N. Nallamshetty, W. Xing, C. Feng, T.M. Laidlaw, and S. Uematsu Prostaglandin E(2) exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation J Immunol 184 2010 433 441
57. K.R. Lynch, G.P. O'Neill, Q. Liu, D.S. Im, N. Sawyer, and K.M. Metters Characterization of the human cysteinyl leukotriene Cys-LT1 receptor Nature 399 1999 789 793
58. E. Makino, T. Ohashi, H. Takahashi, H. Kato, Y. Ito, and H. Nagai Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs J Pharm Pharmacol 42 1990 236 241
59. T. Matsuoka, M. Hirata, H. Tanaka, Y. Takahashi, T. Murata, and K. Kabashima Prostaglandin D2 as a mediator of allergic asthma Science 287 2000 2013 2017
60. N. Matsuura, H. Mori, H. Nagai, and A. Koda Effect of suplatast tosilate (IPD-1151T) on antibody formations in mice Nippon Yakugaku Zasshi 100 1992 485 493 (In Japanese)
61. N. Matsuura, H. Mori, H. Nagai, and A. Koda Effect of suplatast tosilate (IPD-1151T) on type I-IV allergic reactions Nippon Yakugaku Zasshi 100 1992 495 501 (In Japanese)
62. K.M. Metters Leukotriene receptor J Lipid Mediat Cell Signal 12 1995 413 427
63. E. Milian, and A.M. Diaz Allergy to house dust mites and asthma P R Health Sci J 23 2004 47 57
64. W.C. Moore, and R.M. Pascual Update in asthma 2009 Am J Respir Crit Care Med 181 2010 1181 1187
65. Y. Motobayashi, W. Imagawa, and K. Saida Ramatroban (Baynas): a review of its pharmacological and clinical profile Nippon Yakurigaku Zasshi 118 2001 397 402 (In Japanese)
66. M.H. Muz, F. Deveci, Y. Bulut, N. Ilhan, H. Yekeler, and T. Turgut The effect of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model Exp Mol Med 38 2006 109 118
67. S. Myou, M. Fujimura, K. Kurashima, T. Kita, H. Tachibana, and Y. Ishiura Effects of suplatast tosilate, a new type of anti-allergic agent, on airway cough hypersensitivity induced by airway allergy in guinea pigs Clin Exp Allergy 31 2001 1939 1944
68. H. Nagai, A. Arimura, K. Yoshitake, T. Iwama, T. Sakurai, and A. Koda The effect of a novel thromboxane A2 (TXA2) receptor antagonist (S-1452) on the antigen-induced bronchoconstriction and airway hyperresponsiveness in guinea pigs Prostaglandins Leukot Essent Fatty Acids 48 1993 343 349
69. H. Nagai, T. Iwamoto, T. Nishiyori, T. Takizawa, H. Tsuchiya, and A. Koda Pharmacological studies on newly synthesized anti-allergic agents, 2-methyl-3-piperidino-beta-propionaphtone hydrochloride (KZ-111) and 3-isobutyryl-2-isopropylpyrazole-[1,5-a] pyridine (KC-404) Jpn J Pharmacol 33 1983 1215 1223
70. H. Nagai, H. Kawasaki, H. Takeda, Y. Takaoka, and N. Inagaki The effect of a TXA2 receptor antagonist ON-579 on experimental allergic reactions Prostaglandins Leukot Essent Fatty Acids 53 1995 123 133
71. H. Nagai, M. Kumimoto, K. Yoshitake, T. Iwama, A. Arimura, and A. Koda The effect of three novel thromboxane A2 receptor antagonists (S-1452, AA-2414 and ONO-3708) on the increase in pulmonary pressure caused by Forssman anaphylaxis in guinea-pigs Prostaglandins Leukot Essent Fatty Acids 45 1992 233 238
72. H. Nagai, N. Matsuura, N. Sato, A. Koda, and S. Kohno Immunopharmacological studies on mydocalm and related compounds as an antagonist of slow reacting substance of anaphylaxis (SRS-A) J Pharmacobiodyn 6 1983 874 880
73. H. Nagai, H. Takeda, S. Yamaguchi, H. Tanaka, A. Matsuo, and N. Inagaki The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions Prostaglandins 50 1995 75 87
74. H. Nagai, F. Tsuji, S. Goto, and A. Koda Pharmacological modulation of antigen-induced airway hyperresponsiveness by thromboxane A2 inhibitors in guinea pigs Biol Pharm Bull 16 1993 1099 1103
75. H. Nagai, F. Tsuji, N. Inagaki, K. Kitagaki, O. Fukutomi, and A. Koda The effect of ONO-3078, a novel TxA2 receptor antagonist, on U-46619-induced contraction of guinea pig and human tracheal strips in vitro and on bronchoconstriction in guinea pigs in vivo Prostaglandins 41 1991 375 382
76. H. Nagai, I. Yakuo, A. Arimura, S.H. Choi, N. Inagaki, and A. Koda Anti-asthmatic activity of newly synthesized calcium antagonists: 2-n-butyl-1 (N-methyl-n-[2-(N′, N′-dimethylamino)ethyl] amino)-5,6- methylenedioxy-indene and -indane Int Arch Allergy Appl Immunol 90 1989 137 143
77. H. Nagai History of researches on allergic lipid mediators Ther Res 19 1998 493 506 (in Japanese)
78. H. Nagai New perspectives in anti-asthma drugs Nippon Rinsho 59 2001 2000 2006 (In Japanese)
79. H. Nagai Present status and future prospects of anti-allergic drugs Nippon Jibiinkoka Gakkai Kaiho 112 2009 53 59 (in Japanese)
80. K. Nagao, H. Tanaka, M. Komai, T. Masuda, S. Narumiya, and H. Nagai Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice Am J Respir Cell Mol Biol 29 2003 314 320
81. A. Nair, L. McKinlay, P. Williamson, P. Short, P. Burns, and B.J. Lipworth Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers Eur J Clin Pharmacol 67 2011 355 363
82. J. Nakata, M. Kondo, J. Tamaoki, T. Takemiya, M. Nohara, and K. Yamagata Augmentation of allergic inflammation in the airways of cyclooxygenase-2- deficient mice Respirology 10 2005 149 156
83. S. Narita, H. Shirasaki, J. Itoh, K. Kobayashi, and T. Himi Study of thromboxane A2 antagonist reduction in the treatment of patients with perennial allergic rhinitis Arerugi 53 2004 601 604 (In Japanese)
84. S. Narumiya, and T. Furuyashiki Fever, inflammation, pain and beyond: prostanoid receptor research during these 25 years FASEB J 25 2011 813 818
85. P.M. O'Byrne Global guidelines for asthma management: summary of the current status and future challenges Pol Arch Med Wewn 120 2010 511 517
86. A. Oakley Glutathione transferees Drug Metab Rev 43 2011 138 151
87. N. Oda, K. Minoguchi, A. Tanaka, T. Yokoe, H. Minoguchi, and H. Matsuo Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells Clin Exp Allergy 32 2002 1782 1786
88. N. Oda, K. Minoguchi, T. Yokoe, T. Hashimoto, K. Wada, and M. Miyamoto Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen- specific human Th1 and Th2 cell lines Life Sci 65 1999 763 770
89. T. Oguma, K. Asano, and A. Ishizaka Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma Allergol Int 57 2008 307 312
90. C. Ohnmacht, C. Schwartz, M. Panzer, I. Schiedewitz, R. Naumann, and D. Voehringer Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths Immunity 33 2010 364 374
91. K. Ohta, M. Yamaguchi, K. Akiyama, M. Adachi, M. Ichinose, and K. Takahashi Japanese guideline for adult asthma Allergol Int 60 2011 115 145
92. S.J. Pan, C.H. Kuo, K.P. Lam, Y.T. Chu, W.L. Wang, and C.H. Hung Probiotics and allergy in children-an update review Pediatr Allergy Immunol 21 2010 659 666
93. T.L. Remington, A.M. Heaberlin, and B. DiGiovine Combined budesonide/formoterol turbuhaler treatment of asthma Ann Pharmacother 36 2002 1918 1928
94. G. Riccioni, T. Bucciarelli, B. Mancini, C. Di Ilio, and N. D'Orazio Antileukotriene drugs: clinical application, effectiveness and safety Curr Med Chem 14 2007 1966 1977
95. E. Ricciotti, and G.A. FitzGerald Prostaglandin and inflammation Arterioscler Thromb Vasc Biol 31 2011 986 1000
96. D.F. Robbiani, R.A. Finch, D. Jäger, W.A. Muller, A.C. Sartorelli, and G.J. Randolph The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes Cell 103 2000 757 768
97. L.J. Rosenwasser Mechanism of IgE inflammation Curr Allergy Asthma Rep 11 2011 178 183
98. M. Roth, P.R. Johnson, J.J. Rüdiger, G.G. King, Q. Ge, and J.K. Burgess Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling Lancet 360 2002 1293 1299
99. P. Ruiz, L. Rey, R. Spurney, T. Coffman, and A. Viciana Thromboxane augmentation of alloreactive T cell function Transplantation 54 1992 498 505
100. T. Sano, H. Ueda, and H. Bando A preliminary study of PEFR monitoring in patients with chronic cough Lung 182 2004 285 295
101. Y. Sano, Y. Nakamura, H. Yanagawa, H. Bando, A. Nii, and S. Yoshida Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids Lung 181 2003 227 235
102. Y. Sano, N. Suzuki, H. Yamada, Y. To, C. Ogawa, and K. Ohta Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma J Allergy Clin Immunol 111 2003 958 966
103. G.W. Scadding, and G.K. Scadding Recent advances in antileukotriene therapy Curr Opin Allergy Clin Immunol 10 2010 370 376
104. H.G. Schaible, A. Ebersberger, and G. Natura Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines Arthritis Res Ther 13 2011 210
105. R. Schuligoi, E. Sturm, P. Luschnig, V. Konya, S. Philipose, and M. Sedej CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases Pharmacology 85 2010 372 382
106. M.R. Sears, and F. Radner Safety of budesonide-formoterol maintenance and reliever therapy in asthma trials Respir Med 103 2009 1960 1968
107. M. Shichijo, A. Arimura, Y. Hirano, K. Yasui, N. Suzuki, and M. Deguchi A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep Clin Exp Allergy 39 2009 1404 1414
108. J.J. Shim, K. Dabbagh, K. Takeyama, P.R. Burgel, T.P. Deo-Pick, and I.F. Ueki Suplatast tosilate inhibits goblet cell metaplasia of airway epithelium in sensitized mice J Allergy Clin Immunol 105 2000 739 745
109. T. Shioya, M. Satake, M. Kagoya, A. Watanabe, K. Sato, and T. Ito Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma Eur J Clin Pharmacol 58 2002 171 176
110. S. Singh, and Y.K. Loke An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis 5 2010 189 195
111. J.M. Spergel Epidemiology of atopic dermatitis and atopic march in children Immunol Allergy Clin North Am 30 2010 269 280
112. K.J. Stebbins, A.R. Broadhead, L.D. Correa, J.M. Scott, Y.P. Truong, and B.A. Stearns Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation Eur J Pharmacol 638 2010 142 149
113. H. Suda, H. Nagai, T. Miura, T. Iwama, and A. Koda Effect of a newly synthesized leukotriene antagonist, NZ-107, on immediate-type hypersensitivity reaction in rats and guinea-pigs Prostaglandins Leukot Essent Fatty Acids 47 1992 41 49
114. M. Suda, T. Okuda, M. Ishimura, S. Kurokawa, S. Tokuoka, and T. Nakamura The effects of inhaled KP-496, a novel dual antagonist for cysteinyl leukotriene receptor and thromboxane A(2) receptor, on allergic asthmatic responses in guinea pigs Pharmacology 84 2009 249 256
115. T. Suwaki, D.K. Agrawal, and R.G. Townley Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug Int Immunopharmacol 1 2001 2163 2171
116. Y. Takahashi, S. Tokuoka, T. Masuda, Y. Hirano, M. Nagao, and H. Tanaka Augmentation of allergic inflammation in prostanoid IP receptor deficient mice Br J Pharmacol 137 2002 315 322
117. J. Tamaoki, M. Kondo, N. Sakai, K. Aoshiba, E. Tagaya, and K. Nakata Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double blind randomised study Lancet 356 2000 273 278
118. J. Tamaoki, K. Takeyama, K. Aoshiba, J. Nakata, K. Nishimura, and A. Nagai A Th2 cytokine inhibitor for airway inflammation in mild asthma J Allergy Clin Immunol 111 2003 197
119. H. Tanaka, H. Nagai, H. Takeda, S. Yamaguchi, A. Matsuo, and N. Inagaki The effect of a novel leukotriene C4/D4 antagonist, BAY-x-7195, on experimental allergic reactions Prostaglandins 50 1995 269 285
120. N. Terada, T. Yamakoshi, M. Hasegawa, H. Tanikawa, K. Maesako, and K. Ishikawa The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis Acta Otolaryngol 537 1998 32 37
121. G.R. Tintinger, C. Feldman, A.J. Theron, and R. Anderson Montelukast: more than a cysteinyl leukotriene receptor antagonist? Scientific World Journal 10 2010 2403 2413
122. T.M. Tran, R. Jorgensen, and R.B. Clark Phosphorylation of the beta2-adrenergic receptor in plasma membranes by intrinsic GRK5 Biochemistry 46 2007 14438 14449
123. L. Uller, J.M. Mathiesen, L. Alenmyr, M. Korsgren, T. Ulven, and T. Högberg Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation Respir Res 8 2007 16
124. J. Unitt, and D. Hornigold Plant lectins are novel Toll-like receptor agonists Biochem Pharmacol 81 2011 1324 1328
125. T. Uno, H. Tanaka, and H. Nagai Cysteinyl leukotrienes do not mediate lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs Prostaglandins 52 1996 447 461
126. D.J. Vaughan, E.E. Millman, V. Godines, J. Friedman, T.M. Tran, and W. Dai Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation J Biol Chem 281 2006 7684 7692
127. M. Wada, S. Nagata, T. Kudo, T. Shimizu, and Y. Yamashiro Effect of suplatast tosilate on anti-leukotriene non-responders with mild-to-moderate patient asthma Allergol Int 58 2009 389 393
128. Z. Wang, W. Li, H. Chen, and W. Zhang Effect of sublingual immunotherapy on level of cytokines in PBMC of patients with allergic asthma J Huazhong Univ Sci Technolog Med Sci 31 2011 376 378
129. T. Yamada, Y. Takahashi, M. Ishizaki, K. Musoh, T. Ohashi, and H. Tanaka Effects of RS-601, a novel leukotriene D(4)/thromboxane A(2) dual receptor antagonist, on asthmatic responses in guinea pigs Pharmacology 69 2003 51 58
130. K. Yamanaka, and H. Mizutani The role of cytokines/chemokines in the pathogenesis of atopic dermatitis Curr Probl Dermatol 41 2011 80 92
131. Y. Yanagihara, M. Kiniwa, K. Ikizawa, T. Shida, N. Matsura, and A. Koda Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethyl sulfonium agent: (2). Regulation of human IgE response Jpn J Pharmacol 61 1993 31 39
132. Y. Yanagihara, M. Kiniwa, K. Ikizawa, H. Yamaya, T. Shida, and N. Matsura Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethyl sulfonium agent: (1). Regulation of murine IgE response Jpn J Pharmacol 61 1993 23 30
133. S. Yoshihara, M. Ono, Y. Yamada, H. Fukuda, T. Abe, and O. Arisaka Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study Pediatr Allergy Immunol 20 2009 486 492
134. G.D. Zhao, A. Yokoyama, N. Kohno, K. Sakai, H. Hamada, and K. Hiwada Effect of suplatast tosilate (IPD-1151T) Int Arch Allergy Immunol 121 2000 116 122